Sotigalimab Chemische Eigenschaften,Einsatz,Produktion Methoden

Pharmakologie

Sotigalimab binds to CD40 on a variety of immune cell types. This triggers the cellular proliferation and activation of antigen-presenting cells (APCs), and activates B cells, and effector and memory T cells. This results in an enhanced immune response against tumor cells. Sotigalimab also binds to and activates CD40 present on the surfaces of some solid tumor cells, leading to apoptosis and decreased tumor growth.

Sotigalimab Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Sotigalimab Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
ShangHai Biochempartner Co.,Ltd	177-54423994 17754423994	2853530910@QQ.com	China	8010	62
Guangzhou Hongyuan Chemical Co.,Ltd	15817493340	981810490@qq.com	China	1566	58
Wuhan Chemstan Biotechnology Co., Ltd.	027-65317797 15926423062	422450190@qq.com	China	10362	58
Biolab Reagents	027-65279366 18162686757	products@biolabreagent.com	China	9818	58
Wuhan Jingkangen Biomedical Technology Co., Ltd	13720134139 13720134139	orders@jknbiochem.com	China	5797	58
Shanghai Aladdin Biochemical Technology Co.,Ltd.	+86-18521732826	market@aladdin-e.com	China	48461	58
Changsha Fuzhen Biotechnology Co.，LTD	13823398779 18670069958	3062105966@qq.com	China	3262	58
Olix (Shanghai) Pharmaceutical Technology Co., Ltd	17316404525	209533805@qq.com	China	9762	58
Wanxin Biotechnology (Jiaxing) Co., LTD	0573-83568680 18057391398	3956524501@qq.com	China	1441	58

---

• Sotigalimab
• Research Grade Sotigalimab(DHD68911)
• Sotigalimab (anti-CD40)
• 2305607-45-6